SUB-TYPE:
To help keep our customers informed of changes to our service, we have published our 2026 World Cup bank holiday opening hours for pharmacy and retail customers in Scotland:
SUB-TYPE: CLASS 3 RECALL
Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg Gastro-resistant tablets.
MHRA drug alert link: Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21 - GOV.UK
MHRA drug alert date:23/04/26
Pip code | Product description | Supplier | Batch Numbers |
4365961 | NAPRALIEF 9S | OMEGA PHARMA LIMITED | B51496 |
Further Information
For all medical information enquiries, stock control queries and information on this product, please email UKLOcustomerservice@perrigo.com or call +44 0203 598 9603.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).
MHRA drug alert Date: 26/3/26
MHRA drug alert link: Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20 - GOV.UK
Pip code | Product description | Supplier | Batch Numbers |
8062713 | PI HIPREX TAB 1G | Doncaster Pharma Limited | 251352/BA |
This is a caution in use only we are not accepting stock returns
Further Information
For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk, or telephone 01302 365 000.
For stock control enquiries, please email commercial@doncasterpharma.co.uk, or telephone 01302 365 000.
SUB-TYPE: CLASS 2 RECALL
Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.
MHRA drug alert link: Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19 - GOV.UK
MHRA drug alert date:20/04/26
Pip code | Product description | Supplier | Batch Numbers |
1117878 | RAMIPRIL CAP 10MG ALM | Crescent Pharma | GR174091 |
1112606 | RAMIPRIL CAP 10MG ACC | Crescent Pharma | GR174091 |
1276070 | RAMIPRIL CAP 10MG SDZ | Crescent Pharma | GR174091 |
1111541 | RAMIPRIL CAP 10MG TEV | Crescent Pharma | GR174091 |
1219500 | RAMIPRIL CAP 10MG WCK | Crescent Pharma | GR174091 |
Further Information
For all medical information enquiries and information, please email medinfo@crescentpharma.com, for reporting of side effects email safety@crescentpharma.com or telephone +44 1217901596 and for stock control enquiries please email complaints@crescentpharma.com
SUB-TYPE:
In Spring 26, Mandeep Mudhar, Head of Alphega Pharmacy UK, sat down with Boo Dhaliwal from Pharmacy Planet to discuss the importance of community pharmacy, leadership, strategy and more.
Mandeep highlights opportunities in prescribing, NHS services, and wellness, while showcasing Alphega’s support through mentoring, compliance, and strategic guidance for pharmacy growth. The discussion also explores the challenges faced by independent community pharmacies today.
The conversation covers:
• Mandeep’s journey from academia to pharmacy leadership
• The shift from dispensing-focused pharmacies to service-led care
• The operational challenges facing independent contractors
• How pharmacies can improve efficiency and category growth
• The future of independent prescribing and NHS services
• OTC, wellness, and supplement opportunities in pharmacy
• How Alphega supports pharmacies with mentoring and compliance
Watch the full video here: Pharmacy Leadership: From Academia to the Frontline – Mandeep Mudhar’s Journey - YouTube
SUB-TYPE:
To help keep our customers informed of changes to our service, we have published our May 2026 bank holiday opening hours for pharmacy and retail customers:
Early May bank holiday opening hours
Early May bank holiday opening hours (for Channel Islands and Isle of Man)
Spring 2026 bank holiday opening hours
Spring 2026 bank holiday opening hours (for Channel Islands and Isle of Man)
SUB-TYPE: CLASS 2 RECALL
Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the Human Rabies immunoglobulin.
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bio-products-laboratory-limited-rabies-human-normal-immunoglobulin-500iu-solution-for-injection-el-26-a-slash-18
MHRA drug alert date:30/03/26
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | Rabies, Human normal Immunoglobulin 500IU solution for Injection | Bio Products Laboratory Limited | JRC24208 |
Further Information
For all medical information enquiries and information on this product, please email medinfo@bpl.co.uk or medinfo@kedrion.com or telephone +44 (0)20 89572255, +44 (0)20 89572622 or +44 (0)20 89572200
For stock control enquiries please email bplorders@kedrion.com, or telephone +44 (0)20 89572251
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.
MHRA drug alert Date: 26/3/26
MHRA drug alert link:Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 - GOV.UK
Pip code | Product description | Supplier | Batch Numbers |
1258888 | Apixaban 5mg Tablets (56) | Sandoz Limited | PS2891 PT0565 PT1417 PU0476 PU0481 |
1258870 | Apixaban 5mg Tablets (28)
| Sandoz Limited | PV5375 PW1623 PW1624 |
1258896 | Apixaban 2.5mg Tablets (10) | Sandoz Limited | PT1722 |
1258904 | Apixaban 2.5mg Tablets (20) | Sandoz Limited | PU3287
|
1258862 | Apixaban 2.5mg Tablets (60) | Sandoz Limited | PU1963 PT4596 PT2868 PU2604 PU2605 PU2606 |
This is a caution in use only we are not accepting stock returns
Further Information
For all medical information enquiries and information on this product, please email mi.uk@sandoz.com, or telephone +44 1276 698101.
For stock control enquiries please email sales.sandoz-gb@sandoz.com, or telephone +44 1276 698020.
SUB-TYPE: CLASS 4 CAUTION IN USE
Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton.
MHRA drug alert Date: 26/3/26
MHRA drug alert link:Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16 - GOV.UK
pip code | Product description | Supplier | Batch Numbers |
8414435 | PI VESOMNI TABS 6+0.4 MG | Quadrant Pharmaceuticals Limited | 4097Y |
This is a caution in use only we are not accepting stock returns
Further Information
For all medical information enquiries and information on this product, please email maxearnqa@maxearn.co.uk or telephone 01204 471269.
For stock control enquiries please email maxearnqa@maxearn.co.uk or telephone 01204 471269.
SUB-TYPE: CLASS 2 RECALL
Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring.
MHRA drug alert date:23/03/26
Pip code | Product description | Supplier | Batch Numbers |
4285383 | HIBIWASH 4% 500ML | MOLNLYCKE HEALTHCARE | 5156042 |
Further Information
For medical information enquiries please use contact: Vigilance@molnlycke.com or telephone: +46 31 722 30 00. For stock queries please contact: UK Responsible Person: mohammad.humadi@molnlycke.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to